Related references
Note: Only part of the references are listed.Antibiotics Versus Conservative Surgery for Treating Diabetic Foot Osteomyelitis: A Randomized Comparative Trial
Jose Luis Lazaro-Martinez et al.
DIABETES CARE (2014)
Phase 3 study comparing tigecycline and ertapenem in patients with diabetic foot infections with and without osteomyelitis
Laszlo Lauf et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2014)
Self-Reported Quality of Life and Diabetic Foot Infections
Katherine M. Raspovic et al.
JOURNAL OF FOOT & ANKLE SURGERY (2014)
Efficacy and safety of IV/PO moxifloxacin and IV piperacillin/tazobactam followed by PO amoxicillin/clavulanic acid in the treatment of diabetic foot infections: results of the RELIEF study
N. C. Schaper et al.
INFECTION (2013)
Granulocyte-colony stimulating factors as adjunctive therapy for diabetic foot infections
Mario Cruciani et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)
2012 Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infections
Benjamin A. Lipsky et al.
CLINICAL INFECTIOUS DISEASES (2012)
A systematic review of the effectiveness of interventions in the management of infection in the diabetic foot
E. J. G. Peters et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2012)
Expert opinion on the management of infections in the diabetic foot
B. A. Lipsky et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2012)
Topical Application of a Gentamicin-Collagen Sponge Combined with Systemic Antibiotic Therapy for the Treatment of Diabetic Foot Infections of Moderate Severity A Randomized, Controlled, Multicenter Clinical Trial
Benjamin A. Lipsky et al.
JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION (2012)
An Open-label, Three-arm Pilot Study of the Safety and Efficacy of Topical Microcyn Rx Wound Care versus Oral Levofloxacin versus Combined Therapy for Mild Diabetic Foot Infections
Adam Landsman et al.
JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION (2011)
De Marco Formula effectiveness as an adjunctive therapy to prevent infected ischemic diabetic foot amputation and reduce plasma fibrinogen
Milagros Garcia Mesa et al.
JOURNAL OF TISSUE VIABILITY (2011)
Piperacillin/tazobactam versus imipenem/cilastatin for severe diabetic foot infections: a prospective, randomized clinical trial in a university hospital
N. Saltoglu et al.
CLINICAL MICROBIOLOGY AND INFECTION (2010)
A Randomized Controlled Trial to Examine the Efficacy and Safety of a New Super-Oxidized Solution for the Management of Wide Postsurgical Lesions of the Diabetic Foot
A. Piaggesi et al.
INTERNATIONAL JOURNAL OF LOWER EXTREMITY WOUNDS (2010)
Pharmacotherapy of diabetic foot osteomyelitis
I. Byren et al.
EXPERT OPINION ON PHARMACOTHERAPY (2009)
Spectrum of microbial flora in diabetic foot ulcers
Ashish Garg et al.
Indian Journal of Pathology and Microbiology (2009)
Efficacy and Safety of Sequential Intravenous/Oral Moxifloxacin vs Intravenous/Oral Amoxicillin/Clavulanate for Complicated Skin and Skin Structure Infections
R. Vick-Fragoso et al.
INFECTION (2009)
A randomized, double-blind trial comparing ceftobiprole medocaril with vancomycin plus ceftazidime for the treatment of patients with complicated skin and skin-structure infections
Gary J. Noel et al.
CLINICAL INFECTIOUS DISEASES (2008)
Topical versus Systemic Antimicrobial Therapy for Treating Mildly Infected Diabetic Foot Ulcers: A Randomized, Controlled, Double-Blinded, Multicenter Trial of Pexiganan Cream
Benjamin A. Lipsky et al.
CLINICAL INFECTIOUS DISEASES (2008)
Outcome of diabetic foot osteomyelitis treated nonsurgically - A retrospective cohort study
Eric Senneville et al.
DIABETES CARE (2008)
Diabetic foot osteomyetitis: a progress report on diagnosis and a systematic review of treatment
A. R. Berendt et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2008)
Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin-tazobactam/amoxicillin-clavulanate
Benjamin A. Lipsky et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial
BA Lipsky et al.
LANCET (2005)
Daptomycin for treating infected diabetic foot ulcers: evidence from a randomized, controlled trial comparing daptomycin with vancomycin or semi-synthetic penicillins for complicated skin and skin-structure infections
BA Lipsky et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Treating foot infections in diabetic patients: A randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate
BA Lipsky et al.
CLINICAL INFECTIOUS DISEASES (2004)
Evaluation of granulocyte-colony stimulating factor (Filgrastim) in infected diabetic foot ulcers
T Kastenbauer et al.
DIABETOLOGIA (2003)
Once-daily, high-dose levofloxacin versus ticarcillin-clavulanate alone or followed by amoxicillin-clavulanate for complicated skin and skin-structure infections: A randomized, open-label trial
DR Graham et al.
CLINICAL INFECTIOUS DISEASES (2002)
Ertapenem once daily versus piperacillin-tazobactam 4 times per day for treatment of complicated skin and skin-structure infections in adults: Results of a prospective, randomized, double-blind multicenter study
DR Graham et al.
CLINICAL INFECTIOUS DISEASES (2002)
Effects of granulocyte-colony stimulating factor in the treatment of diabetic foot infection
A Yönem et al.
DIABETES OBESITY & METABOLISM (2001)
Randomized prospective controlled trial of recombinant granulocyte colony-stimulating factor as adjunctive therapy for limb-threatening diabetic foot infection
F de Lalla et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Clinafloxacin versus piperacillin-tazobactam in treatment of patients with severe skin and soft tissue infections
G Siami et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Share Paper
